Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
HiberCell
AddedFeb 15, 2024
UpdatedJun 18, 2026
HiberCell

HiberCell

Series C

HiberCell: A pioneering drug development company focused on combating metastatic cancer.

HQ
New York City, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

HiberCell is a pioneering drug development company dedicated to combating metastatic cancer. As the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumor dormancy, HiberCell aims to address the significant challenge of treatment resistance, cancer relapse, and metastasis. Their innovative approach targets adaptive stress mechanisms in tumors, striving to develop differentiated treatments that enable patients to live longer, healthier lives.

HiberCell has made significant strides in the field of oncology by focusing on novel therapeutic strategies that address the root causes of cancer persistence and recurrence. Their work has garnered attention for its potential to transform cancer treatment paradigms and improve patient outcomes. By leveraging cutting-edge research and development, HiberCell continues to push the boundaries of cancer therapy, making a profound impact on the lives of those affected by metastatic cancer.

HiberCell - Similar Companies

HebeCell logo

HebeCell

hebecellcorp.com

Cellvie logo

Cellvie

cellvie.bio

Hibernaid logo

Hibernaid

Cellevolve Bio logo

Cellevolve Bio

cellevolve.com

ExpressCells logo

ExpressCells

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Cellular Approaches logo

Cellular Approaches

MelliCell logo

MelliCell

mellicell.com

Cellworks logo

Cellworks

Cell Care Therapeutics logo

Cell Care Therapeutics

cell-care.com

SymbioCellTech logo

SymbioCellTech

symbiocelltech.com

Celltheon logo

Celltheon

celltheon.com

Empiri logo

Empiri

empiricancer.com

Cellular Engineering Technologies logo

Cellular Engineering Technologies

celleng-tech.com

CellVax Therapeutics logo

CellVax Therapeutics

cellvx.com

HiberCell - Quick Facts

Who are HiberCell's competitors?

Companies similar to HiberCell include HebeCell, Cellvie, Hibernaid and Cellevolve Bio.

When was HiberCell founded?

HiberCell was founded in 2019.

Where is HiberCell's headquarters located?

HiberCell's headquarters is located in New York City, NY, US.

When was HiberCell's last funding round?

HiberCell's most recent funding round was for $30M (USD) in May 2021.

How much has HiberCell raised to-date?

As of May 19, 2021, HiberCell has raised a total of $158.2M (USD).

How many employees does HiberCell have?

HiberCell has 87 employees as of Feb 4, 2024.

HiberCell - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research